Skip to main content
ConductScienceScienceDex

Kuliopulos, Athan

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #5,312
Unclaimed recordClaim profile
  • Sustained Excellence
  • R01 Holder
  • Long-Funded

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2023

Linked Award Amount
$1.6M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#5,312
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Kuliopulos, Athan. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2023 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Kuliopulos, Athan as a PI. Multi-PI records show the full award amount for context.

  • 2R42HL160429-02R42Contact PI
    Lipid Receptor GPR31 as a Target for Anti-Thrombotic and Stroke Therapy
    Oasis Pharmaceuticals
    $999.8K
    award amount
  • 5R01DK128364-02R01Contact PI
    Metabolic Reprogramming by Protease-activated Receptor 2
    Tufts Medical Center · Internal Medicine (investigator's affiliation)
    $591.3K
    award amount

Award organizations

Organizations that administered FY2023 awards listing Kuliopulos, Athan as a PI.

Oasis Pharmaceuticals
MA
$999.8K
1 grant
Tufts Medical Center
MA
$591.3K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2006
    First NIH Award
    Oasis Pharmaceuticals
  2. 2007
    $500K Cumulative Funding
  3. 2007
    $1M Cumulative Funding
  4. 2007
    Entered Top 50% Nationally
    Ranked #5733
  5. 2007
    Multi-Institutional Research
    Awards at 2 institutions
  6. 2008
    $2M Cumulative Funding
  7. 2009
    Entered Top 25% Nationally
    Ranked #2835
  8. 2010
    $5M Cumulative Funding
  9. 2012
    R01 Grant Holder
  10. 2013
    $10M Cumulative Funding
  11. 2014
    Entered Top 10% Nationally
    Ranked #1581
  12. 2019
    $25M Cumulative Funding

Explore further

Find collaborators for Kuliopulos, Athan

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →